124 related articles for article (PubMed ID: 37454490)
1. Human papillomavirus maybe is a critical player in the regulation of chemoresistance related factors (P53, Rb, TWIST, Bcl-2, Bcl-XL, c-IAP2, cytochrome C, and caspase 3) in breast cancer.
Haghighi ZMS; Tabatabaei T; Rafigh M; Karampour R; Babaei F; Amjad ZS; Payandeh M; Roozgari M; Bayat M; Doroudian M; Moghoofei M; Nahand JS
Pathol Res Pract; 2023 Aug; 248():154653. PubMed ID: 37454490
[TBL] [Abstract][Full Text] [Related]
2. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
3. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression.
Du J; Chen GG; Vlantis AC; Chan PK; Tsang RK; van Hasselt CA
Cancer Lett; 2004 Mar; 205(1):81-8. PubMed ID: 15036664
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
5. Luteolin induces intrinsic apoptosis via inhibition of E6/E7 oncogenes and activation of extrinsic and intrinsic signaling pathways in HPV-18-associated cells.
Ham S; Kim KH; Kwon TH; Bak Y; Lee DH; Song YS; Park SH; Park YS; Kim MS; Kang JW; Hong JT; Yoon DY
Oncol Rep; 2014 Jun; 31(6):2683-91. PubMed ID: 24789165
[TBL] [Abstract][Full Text] [Related]
6. Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression.
Chuery ACS; Silva IDCGD; Ribalta JCL; Speck NMG
Braz J Infect Dis; 2017; 21(3):248-254. PubMed ID: 28347732
[TBL] [Abstract][Full Text] [Related]
7. Involvement of p53-dependent apoptosis signal in antitumor effect of Colchicine on human papilloma virus (HPV)-positive human cervical cancer cells.
Yan L; Huang H; Zhang Y; Yuan X; Yan Z; Cao C; Luo X
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32163135
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of carcinogenesis by human papillomavirus-16.
Ishiji T
J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
10. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
11. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection.
Huang J; Yin C; Wang J
J Obstet Gynaecol; 2023 Dec; 43(1):2161349. PubMed ID: 36645341
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
14. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and prostate cancer: The role of viral expressed proteins in the inhibition of anoikis and induction of metastasis.
Fatemipour M; Nahand JS; Fard Azar ME; Baghi HB; Taghizadieh M; Sorayyayi S; Hussen BM; Mirzaei H; Moghoofei M; Bokharaei-Salim F
Microb Pathog; 2021 Mar; 152():104576. PubMed ID: 33086103
[TBL] [Abstract][Full Text] [Related]
17. A novel dithiocarbamate derivative induces cell apoptosis through p53-dependent intrinsic pathway and suppresses the expression of the E6 oncogene of human papillomavirus 18 in HeLa cells.
Li Y; Qi H; Li X; Hou X; Lu X; Xiao X
Apoptosis; 2015 Jun; 20(6):787-95. PubMed ID: 25772545
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
[TBL] [Abstract][Full Text] [Related]
20. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
